PRAME expression and clinical outcome of breast cancer

par Epping, M T, Hart, A A M, Glas, A M, Krijgsman, O, Bernards, R
Publié 2008

Marker genes for circulating tumour cells predict survival in metastasized breast cancer patients

par Weigelt, B, Bosma, A J, Hart, A A M, Rodenhuis, S, van 't Veer, L J
Publié 2003

The influence of tamoxifen treatment on the oestrogen receptor in metachronous contralateral breast cancer

par Kaas, R, Peterse, J L, Hart, A A M, Voogd, A C, Rutgers, E J T, van Leeuwen, F E
Publié 2003

Effects of patient selection on the applicability of results from a randomised clinical trial (EORTC 10853) investigating breast-conserving therapy for DCIS

par Bijker, N, Peterse, J L, Fentiman, I S, Julien, J-P, Hart, A A M, Avril, A, Cataliotti, L, Rutgers, E J T
Publié 2002

Cisplatin-DNA adduct formation in patients treated with cisplatin-based chemoradiation: lack of correlation between normal tissues and primary tumor

par Hoebers, F. J. P., Pluim, D., Hart, A. A. M., Verheij, M., Balm, A. J. M., Fons, G., Rasch, C. R. N., Schellens, J. H. M., Stalpers, L. J. A., Bartelink, H., Begg, A. C.
Publié 2007